Purchase Order W81K0017P0073
- Not listed
- This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostic products. The contract, valued at $497,149.96, is for the delivery of human papillomavirus (HPV) detection kits. The contract is not set aside for any type of small business. Roche Diagnostics has been awarded numerous federal contracts and task orders, including through General Services Administration (GSA) schedule...
- This is a firm fixed-price purchase order contract awarded by the Department of Defense's Medical Command (MEDCOM) to Roche Diagnostics Corporation for the provision of COBAS 4800 HPV AMP/DET testing systems and related equipment. The contract has a ceiling value of $125,119.70 and an ultimate completion date of January 27, 2017. Roche Diagnostics, which holds multiple General Services Administration (GSA) Schedule contracts for laboratory instruments and supplies, has a history of providing...
- This is a $115,930.87 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation for COBAS 4800 HPV diagnostic equipment and associated products and services. The contract was awarded on March 7, 2017 with a completion date of the same day. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products that has held multiple General Services Administration (GSA) Schedule...
- The U.S. Department of the Army Medical Command awarded a $115,930.87 delivery order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This contract is for the provision of KIT COBAS 4800 HPV AMP/DET 960T and does not include a set-aside designation. Roche Diagnostics has an established history of providing critical care...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $181,143.20, is for the delivery of HPV (Human Papillomavirus) detection kits. The contract was awarded by the U.S. Army Medical Command (MEDCOM), a Defense agency, and has a completion date of September 30, 2019. The contract is a Firm Fixed Price Purchase Order and does not...
- The Department of the Army Medical Command awarded a $147,548.38 delivery order contract to Roche Diagnostics Corporation for the supply of KIT COBAS 4800 HPV AMP/DET 960T. This award was made under Roche's General Services Administration (GSA) Schedule contract for critical laboratory analyzers and equipment. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has a history of providing medical equipment, reagents, and testing services to various federal agencies,...
- This is a firm-fixed price purchase order awarded to Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM) for the provision of 960 HPV (Human Papillomavirus) detection kits. The contract has a ceiling value of $388,211.32 and a performance period ending on September 30, 2022. The contract was awarded on October 1, 2019 and does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
- This federal contract award was issued by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Roche Diagnostics Corporation for the purchase of COBAS 4800 HPV testing equipment. The $178,000.00 firm fixed-price delivery order was placed against Roche's existing General Services Administration (GSA) schedule contract for critical laboratory analyzers. The contract has no set-aside designation. Roche Diagnostics has a history of providing medical equipment,...
- This contract award to Roche Diagnostics Corporation (Roche) is for the COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0. The contract, which has a ceiling value of $109,459.97, was awarded by the U.S. Army Medical Command (MEDCOM) for the delivery of this diagnostic test and is a firm fixed price Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation. Roche is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2, is for HPV detection cost-per-test services during the option year 1 period. The contract has a ceiling value of $105,293.00 and is a firm fixed price Blanket Purchase Agreement (BPA) call order. The...
This is a firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services. The contract, valued at $115,930.87, is for the provision of COBAS 4800 HPV AMP/DET 960T test kits. This award does not have a set-aside designation. Roche Diagnostics has received numerous federal contract awards, including through General Services Administration (GSA) Schedules and Indefinite Delivery Contracts (IDCs), to supply medical equipment, reagents, and laboratory testing services to various government agencies such as the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. The current award appears to be a standalone purchase order, rather than part of a larger contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($42k) | 8/22/20 | |
| P00001 | Funding Only Action | $42.2k | 2/2/17 | |
| Not listed | Not listed | $115.9k | 11/29/16 |